- All Courts
- Federal Courts
- Bankruptcies
- PTAB
- ITC
Filters
Like full text docket searches?
Get docket alerts, perform legal research, get updates of major decisions and orders, use our advanced analytics, and more. Request a Demo or create your account.
Date Filed
Dollars
Find cases based on dollar amount with searches like:
$100k-$10M.
Read the details here.
Displaying 309-323 of
645 results
2033 Exhibit: Kaken Exhibit 2033
Document
IPR2017-00190, No. 2033-80 Exhibit - Kaken Exhibit 2033 (P.T.A.B. Aug. 1, 2017)
|
|
Cite Document
3001 Exhibit: Ex 3001
Document
IPR2017-00190, No. 3001-347 Exhibit - Ex 3001 (P.T.A.B. Dec. 10, 2018)
|
|
Cite Document
1670 Exhibit: Declaration of Aydin H Harston in Support of Petitioners¿¿¿ Response ...
Document
IPR2017-00190, No. 1670-325 Exhibit - Declaration of Aydin H Harston in Support of Petitioners¿¿¿ Response to Patent Owner¿¿¿s Objections to Evidence Served November 22, 2017 (P.T.A.B. Ja...
|
|
Cite Document
1554 Exhibit: Exhibit 1554a Valeant Pharmaceuticals International, Inc, US Securit...
Document
IPR2017-00190, No. 1554-335 Exhibit - Exhibit 1554a Valeant Pharmaceuticals International, Inc, US Securities and Exchange Commission Form 10 K, for the Fiscal Year Ended December 31,...
|
|
Cite Document
2200 Exhibit: Kaken Exhibit 2200
Document
IPR2017-00190, No. 2200-320 Exhibit - Kaken Exhibit 2200 (P.T.A.B. Dec. 22, 2017)
|
|
Cite Document
1522 Exhibit: Antifungal drugs for onychomycosis efficacy, safety, and mechanism...
Document
IPR2017-00190, No. 1522-171 Exhibit - Antifungal drugs for onychomycosis efficacy, safety, and mechanisms of action (P.T.A.B. Nov. 1, 2017)
|
|
Cite Document
1548 Exhibit: The Fraud Allegations Against Valeant Exposed an Industry Secret th...
Document
IPR2017-00190, No. 1548-197 Exhibit - The Fraud Allegations Against Valeant Exposed an Industry Secret that¿¿¿s going to Infuriate Washington (P.T.A.B. Nov. 1, 2017)
|
|
Cite Document
1600 Exhibit: Valeant Pharmaceuticals International, Inc VRX Q4 2014 Results Ear...
Document
IPR2017-00190, No. 1600-249 Exhibit - Valeant Pharmaceuticals International, Inc VRX Q4 2014 Results Earnings Call Transcript, dated February 23, 2015 (P.T.A.B. Nov. 1, 2017)
|
|
Cite Document
1650 Exhibit: Consolidated Financial Results for Fiscal 2016 Reference Data of Fina...
Document
IPR2017-00190, No. 1650-299 Exhibit - Consolidated Financial Results for Fiscal 2016 Reference Data of Financial Statements for the 2Q of Fiscal 2016, (P.T.A.B. Nov. 1, 2017)
|
|
Cite Document
1639 Exhibit: Top 200 Brand Name Drugs by Retail Sales in 2001
Document
IPR2017-00190, No. 1639-288 Exhibit - Top 200 Brand Name Drugs by Retail Sales in 2001 (P.T.A.B. Nov. 1, 2017)
|
|
Cite Document
1501 Exhibit: Onychomycosis
Document
IPR2017-00190, No. 1501-147 Exhibit - Onychomycosis (P.T.A.B. Nov. 1, 2017)
|
|
Cite Document
1567 Exhibit: The life cycle of a pharmaceutical brand
Document
IPR2017-00190, No. 1567-216 Exhibit - The life cycle of a pharmaceutical brand (P.T.A.B. Nov. 1, 2017)
|
|
Cite Document
2024 Exhibit: Kaken Exhibit 2024
Document
IPR2017-00190, No. 2024-71 Exhibit - Kaken Exhibit 2024 (P.T.A.B. Aug. 1, 2017)
|
|
Cite Document
1536 Exhibit: Prior Authorization,¿¿¿ The Academy of Managed Care Pharmacy¿¿¿s C...
Document
IPR2017-00190, No. 1536-185 Exhibit - Prior Authorization,¿¿¿ The Academy of Managed Care Pharmacy¿¿¿s Concepts in Managed Care Pharmacy (P.T.A.B. Nov. 1, 2017)
|
|
Cite Document
1565 Exhibit: Health Insurance and the Growth in Pharmaceutical Expenditures
Document
IPR2017-00190, No. 1565-214 Exhibit - Health Insurance and the Growth in Pharmaceutical Expenditures (P.T.A.B. Nov. 1, 2017)
|
|
Cite Document
